Global Insulin Glargine Market by Manufacturers, Regions, Type and Application, Forecast to 2021

According to Custom Market Inights analysis, The global insulin glargine market is expected to register a healthy CAGR during the period from 2016 to 2025. This report studies the insulin glargine status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the insulin glargine by product type and applications/end industries.

Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a “peakless” profile (according to the insulin glargine package insert).

Scope of the Report:

This report focuses on the Insulin Glargine in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Sanofi-Aventis

Ganlee

Biocon

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

Latin America, Middle East and Africa

Market Segment by Type, covers

Single Dose Vial

Pre-filled Syringe

Market Segment by Applications, can be divided into

Treat type 1 diabetes

Treat type 2 diabetes

There are 13 Chapters to deeply display the global Insulin Glargine market.

Chapter 1, to describe Insulin Glargine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Insulin Glargine, with sales, revenue, and price of Insulin Glargine, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin Glargine, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Insulin Glargine market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Insulin Glargine sales channel, distributors, traders, dealers, appendix and data source.

Table of Contents

Global Insulin Glargine Market by Manufacturers, Regions, Type and Application, Forecast to 2021

1 Market Overview

1.1 Insulin Glargine Introduction

1.2 Market Analysis by Type

1.2.1 Single Dose Vial

1.2.2 Pre-filled Syringe

1.3 Market Analysis by Applications

1.3.1 Treat type 1 diabetes

1.3.2 Treat type 2 diabetes

1.4 Market Analysis by Regions

1.4.1 North America (USA, Canada and Mexico)

1.4.1.1 USA

1.4.1.2 Canada

1.4.1.3 Mexico

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany

1.4.2.2 France

1.4.2.3 UK

1.4.2.4 Russia

1.4.2.5 Italy

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China

1.4.3.2 Japan

1.4.3.3 Korea

1.4.3.4 India

1.4.3.5 Southeast Asia

1.4.4 Latin America, Middle East and Africa

1.4.4.1 Brazil

1.4.4.2 Egypt

1.4.4.3 Saudi Arabia

1.4.4.4 South Africa

1.4.4.5 Nigeria

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Sanofi-Aventis

2.1.1 Business Overview

2.1.2 Insulin Glargine Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Sanofi-Aventis Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share

2.2 Ganlee

2.2.1 Business Overview

2.2.2 Insulin Glargine Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Ganlee Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share

2.3 Biocon

2.3.1 Business Overview

2.3.2 Insulin Glargine Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Biocon Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share

3 Global Insulin Glargine Market Competition, by Manufacturer

3.1 Global Insulin Glargine Sales and Market Share by Manufacturer

3.2 Global Insulin Glargine Revenue and Market Share by Manufacturer

3.3 Market Concentration Rate

3.3.1 Top 3 Insulin Glargine Manufacturer Market Share

3.3.2 Top 6 Insulin Glargine Manufacturer Market Share

3.4 Market Competition Trend

4 Global Insulin Glargine Market Analysis by Regions

4.1 Global Insulin Glargine Sales, Revenue and Market Share by Regions

4.1.1 Global Insulin Glargine Sales by Regions (2011-2016)

4.1.2 Global Insulin Glargine Revenue by Regions (2011-2016)

4.2 North America Insulin Glargine Sales and Growth (2011-2016)

4.3 Europe Insulin Glargine Sales and Growth (2011-2016)

4.4 Asia-Pacific Insulin Glargine Sales and Growth (2011-2016)

4.5 Latin America Insulin Glargine Sales and Growth (2011-2016)

4.6 Middle East and Africa Insulin Glargine Sales and Growth (2011-2016)

5 North America Insulin Glargine by Countries

5.1 North America Insulin Glargine Sales, Revenue and Market Share by Countries

5.1.1 North America Insulin Glargine Sales by Countries (2011-2016)

5.1.2 North America Insulin Glargine Revenue by Countries (2011-2016)

5.2 USA Insulin Glargine Sales and Growth (2011-2016)

5.3 Canada Insulin Glargine Sales and Growth (2011-2016)

5.4 Mexico Insulin Glargine Sales and Growth (2011-2016)

6 Europe Insulin Glargine by Countries

6.1 Europe Insulin Glargine Sales, Revenue and Market Share by Countries

6.1.1 Europe Insulin Glargine Sales by Countries (2011-2016)

6.1.2 Europe Insulin Glargine Revenue by Countries (2011-2016)

6.2 Germany Insulin Glargine Sales and Growth (2011-2016)

6.3 UK Insulin Glargine Sales and Growth (2011-2016)

6.4 France Insulin Glargine Sales and Growth (2011-2016)

6.5 Russia Insulin Glargine Sales and Growth (2011-2016)

6.6 Italy Insulin Glargine Sales and Growth (2011-2016)

7 Asia-Pacific Insulin Glargine by Countries

7.1 Asia-Pacific Insulin Glargine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Insulin Glargine Sales by Countries (2011-2016)

7.1.2 Asia-Pacific Insulin Glargine Revenue by Countries (2011-2016)

7.2 China Insulin Glargine Sales and Growth (2011-2016)

7.3 Japan Insulin Glargine Sales and Growth (2011-2016)

7.4 Korea Insulin Glargine Sales and Growth (2011-2016)

7.5 India Insulin Glargine Sales and Growth (2011-2016)

7.6 Southeast Asia Insulin Glargine Sales and Growth (2011-2016)

8 Latin America, Middle East and Africa Insulin Glargine by Countries

8.1 Latin America, Middle East and Africa Insulin Glargine Sales, Revenue and Market Share by Countries

8.1.1 Latin America, Middle East and Africa Insulin Glargine Sales by Countries (2011-2016)

8.1.2 Latin America, Middle East and Africa Insulin Glargine Revenue by Countries (2011-2016)

8.2 Brazil Insulin Glargine Sales and Growth (2011-2016)

8.3 Saudi Arabia Insulin Glargine Sales and Growth (2011-2016)

8.4 Egypt Insulin Glargine Sales and Growth (2011-2016)

8.5 Nigeria Insulin Glargine Sales and Growth (2011-2016)

8.6 South Africa Insulin Glargine Sales and Growth (2011-2016)

9 Insulin Glargine Market Segment by Type

9.1 Global Insulin Glargine Sales, Revenue and Market Share by Type (2011-2016)

9.1.1 Global Insulin Glargine Sales and Market Share by Type (2011-2016)

9.1.2 Global Insulin Glargine Revenue and Market Share by Type (2011-2016)

9.2 Single Dose Vial Sales Growth and Price

9.2.1 Global Single Dose Vial Sales Growth (2011-2016)

9.2.2 Global Single Dose Vial Price (2011-2016)

9.3 Pre-filled Syringe Sales Growth and Price

9.3.1 Global Pre-filled Syringe Sales Growth (2011-2016)

9.3.2 Global Pre-filled Syringe Price (2011-2016)

9.4 Sales Growth and Price

9.4.1 Global Sales Growth (2011-2016)

9.4.2 Global Price (2011-2016)

10 Insulin Glargine Market Segment by Application

10.1 Global Insulin Glargine Sales Market Share by Application (2011-2016)

10.2 Treat type 1 diabetes Sales Growth (2011-2016)

10.3 Treat type 2 diabetes Sales Growth (2011-2016)

10.4 Sales Growth (2011-2016)

10.5 Sales Growth (2011-2016)

11 Insulin Glargine Market Forecast (2016-2021)

11.1 Global Insulin Glargine Sales, Revenue and Growth Rate (2016-2021)

11.2 Insulin Glargine Market Forecast by Regions (2016-2021)

11.3 Insulin Glargine Market Forecast by Type (2016-2021)

11.4 Insulin Glargine Market Forecast by Application (2016-2021)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Future Trend

12.2 Distributors, Traders and Dealers

13 Appendix

13.1 Methodology

13.2 Analyst Introduction

13.3 Data Source

Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Jacob Thomass